ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESI....FIRO..CY....................................................JDIM360 Ver 2.15 (14 Jul 2008) - 1999001/02017269CORRECTED EUROPEAN PATENT APPLICATIONA9A320091014W154deBibliographieenBibliographyfrBibliographieEP08007622.71999071920090819enenen0302970919990719EP11934519980720US32609319990604US200910142009422009012120090420091014200942C07D 277/24 20060101AFI20081202BHEP C07D 277/28 20060101ALI20081202BHEP C07D 277/30 20060101ALI20081202BHEP C07D 277/36 20060101ALI20081202BHEP C07D 277/40 20060101ALI20081202BHEP C07D 277/42 20060101ALI20081202BHEP A61K 31/425 20060101ALI20081202BHEP deKrystalline Form II von Ritonavir enthaltende pharmazeutische Zusammensetzung und ihre HerstellungenA pharmaceutical composition comprising form II crystalline Ritonavir and a preparation thereoffrComposition pharmaceutique comprenant forme cristalline II de Ritonavir et procédé de sa préparationNone03029709.714181742003122399934143.1109714819990719ABBOTT LABORATORIES086830904745/MNM/msDept. 377, Bldg AP6A-1 100 Abbott Park RoadAbbott Park, IL 60064-6008USBauer, John F.660 Green Bay RoadLake Bluff, IL 60044USSaleki-Gerhardt, Azita1113 Virginia AvenueLibertyville, IL 60048USChemburkar, Sanjay R.509 Prescott LaneGurnee, IL 60031USPatel, Ketan1710 N. Wilshire AvenueArlington Heights, IL 60004USSpiwek, Harry O.3730 63rd StreetKenosha, WI 53142USModiano, Micaela Nadiaet al00097641Modiano Josif Pisanty & Staub Ltd Thierschstrasse 1180538 MünchenDEATBECHCYDEDKESFIFRGBGRIEITLILUMCNLPTSERO20090819SI2009081920090610200924

This Application concerns the use of Form II crystalline ritonavir as a pharmaceutical agent, as well as methods of preparing pharmaceutical compositions, which methods employ Form II crystalline ritonavir. The Application further concerns methods for obtaining Form I crystalline ritonavir, which methods employ Form II crystalline ritonavir.